|
Clinical Research Trials
Would you like to participate in a clinical research trial? A clinical trial is a research study in human volunteers used to determine whether new drugs or treatments are safe and effective. Clinical testing is preceded by extensive laboratory research, and is normally done in three phases. Participants can help themselves and others by contributing to medical research and advancing the development of better treatments. The potential benefits and risks should be weighed carefully before entering a clinical trial. Explore the resources below to learn more. Where to find clinical trials The following information is presented as a service to those who might be interested in participating in clinical research trials studying atopic dermatitis/eczema. The National Eczema Association (NEA) posts research notices as an informational service only. Such postings do not represent a NEA endorsement of these studies, but serves to make you aware that this clinical study is available for your participation if you choose. If you are presently under the care of a physician for atopic dermatitis/eczema, or other conditions, you should discuss this study with your doctor before altering your treatment program. Postdate: August 18, 2010 Feasibility and Reliability of Internet Crowdsourcing Data Collection with Dermatologic Quality of Life Assessment Tools Please click here if you have been diagnosed with eczema/atopic dermatitis, seborrheic dermatitis, psoriasis, rosacea, or acne and would like to learn more about participating in a clinic research study conducted by the Emory University School of Medicine Department of Dermatology. Principal Investigator Dr. Suephy Chen, Associate Professor, Dept of Dermatology, Emory University Name of the Study/Sponsor: Emory University and CureTogether.com Learn more about the study here > > > Patient recruitment deadline: August 31, 2010 Postdate: May 26, 2010 National Institutes of Health (NIH): Study of Skin Micoflora in Children with Atopic Dermatitis The National Institutes of Health is working on a study to determine how microbes, such as bacteria and fungi, contribute to Atopic Dermatitis in children. With these studies, the NIH hopes to lay the groundwork for development of more effective AD treatments. The study aims to compare the microbes on the skin of children with moderate/severe AD to that of healthy volunteers’ of the same age, who do not have AD. To qualify you must:
The study involves: questions regarding the child’s medical history, physical examination of the child’s skin, blodd draw, skin swabs (and/or scrapes), and nose swabs. Compensation is provided to qualified participants.
Principal Investigator Learn more about the study here > > >
To enroll in the study, contact: Postdate: April 27, 2010 Study Title: A Study of the Systemic and Cutaneous Immune Responses to Yellow Fever Vaccination in Atopic Dermatitis Subjects The National Institutes of Health, Division of Allergy, Immunology and Transplant is sponsoring a new clinical study and is looking for participants in Denver, Colorado; Portland, Oregon; or San Diego, California. To qualify you must:
The study involves: 1 screening visit, 7 visits over a 30 day period, blood draws and subject diary. Compensation is provided to qualified participants.
Principal Investigators:
For further information contact: Postdate: April 9, 2009 Study Title: Atopic Dermatitis Education Survey We are conducting a survey on atopic dermatitis education. We hope the results will be published in a peer-reviewed journal. Please follow this link to participate in the Survey: ![[Bullet]](/images/bullet.gif)
www.surveymonkey.com/s.aspx?sm=o9nKJj7BDoK83FX4lSuwxg_3d_3d
Principal Investigators: Mikael Langner, M.D. and Howard Maibach, M.D., University of California at San Francisco To find out more about this study please contact:Mikael Langner, M.D. Research Associate Department of Dermatology University of California 90 Medical Center Way, Surge #110 San Francisco, CA 94143 415-613-1478 415-613-1478 Postdate: January 19, 2009 Study Title: HANDEL (HAND Eczema research of aLitretinoin) Basilea Pharmaceutical HANDEL Clinical Study (HAND Eczema research of aLitretinoin study) has opened for enrollment. There are currently no approved agents in the United States for the treatment of patients with severe CHE that have failed to respond to potent topical steroids. The HANDEL study is a double-blind, placebo-controlled, randomized clinical trial that will investigate the efficacy and safety of alitretinoin in the treatment of patients with severe CHE who have not responded to potent topical steroids. In the HANDEL study participants will be randomized to receive oral alitretinoin or placebo for up to 24 weeks.
Postdate: December 30, 2008 Study Title: Does Your Atopic Dermatitis (Eczema) Interfere With Your Sleep? Sleep Disturbance in Atopic Dermatitis: a comprehensive investigation of opiates, neuropeptides, barrier function, scratching and sleep physiology. We are studying a medication which is FDA-approved for insomnia, in persons whose atopic dermatitis interferes with their sleep (due to excessive itching and scratching). Dr. Bruce Bender, Principal Investigator / Amanda Calhoun, Study Coordinator To be eligible you must:
Qualified participants may receive physical examinations, ECG's, EEG’s, skin testing, and study drug at no cost. In addition, participants who qualify to participate in the study will be financially compensated. For further information: Please contact our patient recruiters at 303.270.2222
Contact: Postdate: December 30, 2008 Study Title: Atopic Dermatitis (Eczema) Heart Rate Patterns Purpose: The purpose of this research is to study heart rate patterns in people with moderate to severe atopic dermatitis and how itching affects those patterns. To qualify you must:
Length/duration of participant involvement: Your participation may last up to 2 visits.
Location:
Compensation: Qualified participants will be financially compensated up to $75. If you withdraw for any reason from the study before completion you will be paid $25 for completing the first study visit. Whom to contact: Susie Dowd and Penny Bowden (336) 716-3775 DISCLAIMER The National Eczema Association (NEA) announces research as an informational service to its members. This announcement does not represent a NEA endorsement of this study, but makes you aware that this clinical study is available for your participation if you choose. If you are presently under the care of a physician for atopic dermatitis/eczema or other conditions, you should discuss this study with your doctor before altering your treatment program. Other Clinical Trials Clinicaltrials.gov is a registry of federally or privately supported clinical trials conducted in the United States and around the world. |
|